tirzepatide cardiovascular outcomes trial results july 2025 US Population Eligibility and Estimated Impact of Treatment on Obesity Prevalence and Disease Events | Cardiovascular Drugs and Therapy Designing Next-Generation Cardiometabolic Outcome Trials

Retatrutide belongs to a new class of drugs called triple agonists

Can I lose weight without medication

This personalized approach means you can avoid unnecessary discomfort and reach your optimal therapeutic dose faster than a one-size-fits-all protocol

Treatment with tirzepatide met the pre-specified criteria for non-inferiority compared with dulaglutide on the rate of the primary composite endpoint of cardiovascular death, myocardial infarction or stroke

It is also more likely if youre taking a higher dose of tirzepatide

GIP directly regulates hunger circuits through the pathway your body naturally uses, while GLP-1 provides additional suppression through pharmacologic override